Where they are used
stem cells

Development of stem cell treatment

Cells from cord blood were first successfully used in 1988 in France.
A dozen years later, this method was already being used in Poland.
In 2007, cord blood from PBKM was used for the first time.
To date, stem cells from cord blood have been transplanted more than 85,000 times around the world (source: https://parentsguidecordblood.org/en/news/cord-blood-utilization-booming-china), saving lives or health.
In Poland, it is also possible to transplant cord blood.
Today, medicine is moving forward, and the list of diseases for which stem cell transplantation is a therapeutic standard is constantly growing.
See what diseases can be treated with stem cells (according to.
guidelines of the stem cell transplantation organization in Europe – EBMT (European Society for Blood and Marrow Transplantation)).

List of diseases treated with stem cells

Acute leukemia

Acute lymphoblastic leukemia (ALL)

Acute biphenotypic leukemia

Acute myeloid leukemia (AML)

Acute leukemia of little differentiation

Chronic leukemias

Chronic myelogenous leukemia (CML)

Chronic lymphocytic leukemia (CLL)

Juvenile chronic myeloid leukemia (JCML)

Juvenile myelomonocytic leukemia (Naegele’s leukemia) (JMML)

Myelodysplastic syndrome

Refractory anemia (RA)

Refractory anemia with ring-associated sideroblasts (RARS)

Refractory anemia with excess blasts (RAEB)

Refractory anemia with excess blasts in transition (RAEB-T)

Chronic myelomonocytic leukemia (CMML)

Diseases caused by stem cell defect

Aplastic anemia (severe)

Fanconi anemia

Nocturnal paroxysmal hemoglobinuria (PNH)

Myeloproliferative syndromes

Acute myelofibrosis

Myelofibrosis

Genuine melanoma

Spontaneous hyperplasia

Agnogenic myeloid metaplasia

Proliferative syndromes of the lymphatic system

Non-Hodgkin’s lymphoma

Malignant granuloma

Prolymphocytic leukemia

Phagocyte diseases

Chediak-Higashi syndrome

Chronic granulomatous disease (CGD)

Neutrophil actin deficiency

Reticular dysgenesis

Diseases associated with disorders or lack of enzyme function

Hurler syndrome (MPS-IH)

Scheie´ syndrome (MPS-IS)

Hunter syndrome (MPS-II)

Sanfilippo syndrome (MPS-III)

Morquio syndrome (MPS-IV)

Maroteaux-Lamy syndrome (MPS-VI)

stealth syndrome, beta-glucuronidase deficiency (MPS-VII)

adrenoleukodystrophy

mucopolysaccharidosis (MPS)

mucolipidosis II

Krabbe disease

Gaucher disease

Niemann-Pick disease

Wolman’s disease

metachromatic leukodystrophy

Other inherited diseases

Lesch-Nyhan syndrome

cartilage and hair hypoplasia

Glanzmann’s thrombasthenia

osteopetrosis (marbling of the bones)

Hereditary disorders of platelet cells

amegakaryocytosis (congenital thrombocytopenia)

Plasma cell diseases

multiple myeloma

plasmocytic leukemia

Waldenström’s macroglobulinemia

Other malignancies

breast cancer*

Ewing’s sarcoma

Neuroblastoma (ganglioneuroma)

kidney cancer*

Hereditary red blood cell abnormalities

pure red cell aplasia

beta thalassemia

sickle cell anemia

Hereditary disorders of the immune system

ataxia-telangiectasia

Kostmann syndrome

leukocyte adhesion disorders

DiGeorge syndrome

naked lymphocyte syndrome

Omenna band

severe combined immune system failure (SCID)

SCID with adenosine deaminase deficiency

SCID with absence of T and B lymphocytes

SCID with absence of T lymphocytes and normal number of B lymphocytes

simple variable immune system failure

Wiskott Aldrich syndrome

X chromosome-associated lymphocyte proliferation disorder

Histiocytoses

Hemophagocytosis

Histiocytosis-X

Familial erythrophagocytic lymphohistiocytosis (FEL)

*Transplantation in these diseases can be performed in exceptional clinical situations.
It is not the treatment of choice.

Stem cell administration benefits patients with neurological conditions such as autism and cerebral palsy.

Print list of diseases treated with stem cells

Download PDF

Learn about the indications for cord blood stem cell therapy